APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pet Medical Cannabidiol

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Pet Medical Cannabidiol Market Analysis and Forecast 2026-2032

4 July 2026197 pages

Choose your research edition.

Industry ResearchPet Medical Cannabidiol Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Pet Medical Cannabidiol Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Pet Medical Cannabidiol Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pet Medical Cannabidiol Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Pet Medical Cannabidiol Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Pet Medical Cannabidiol market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Pet Medical Cannabidiol is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Pet Medical Cannabidiol is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Pet Medical Cannabidiol is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Pet Medical Cannabidiol is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Pet Medical Cannabidiol include Canna-Pet, Holistic Hound, BATCH, Choom Holdings, Receptra Naturals, Curaleaf, Trulieve Cannabis, Pure Spectrum and Cannabis Strategies Acquisition, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Pet Medical Cannabidiol, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Pet Medical Cannabidiol, also provides the sales of main regions and countries. Of the upcoming market potential for Pet Medical Cannabidiol, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pet Medical Cannabidiol sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pet Medical Cannabidiol market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Pet Medical Cannabidiol sales, projected growth trends, production technology, application and end-user industry.

Pet Medical Cannabidiol Segment by Company

Canna-Pet

Holistic Hound

BATCH

Choom Holdings

Receptra Naturals

Curaleaf

Trulieve Cannabis

Pure Spectrum

Cannabis Strategies Acquisition

Pet Releaf

Diamond CBD

PotNetwork Holdings

Kat's Naturals

Bluebird Botanicals

Pet Medical Cannabidiol Segment by Type

Oral Cannabidiol

Topical Cannabidiol

Pet Medical Cannabidiol Segment by Application

Anaesthetization

Stimulate Appetite

Relieve Anxiety

Others

Pet Medical Cannabidiol Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pet Medical Cannabidiol market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pet Medical Cannabidiol and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pet Medical Cannabidiol.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Pet Medical Cannabidiol in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Pet Medical Cannabidiol manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pet Medical Cannabidiol sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pet Medical Cannabidiol Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Oral Cannabidiol Major Manufacturers Table 3. Topical Cannabidiol Major Manufacturers Table 4. Global Pet Medical Cannabidiol Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Anaesthetization Major Manufacturers Table 6. Stimulate Appetite Major Manufacturers Table 7. Relieve Anxiety Major Manufacturers Table 8. Others Major Manufacturers Table 9. Pet Medical Cannabidiol Industry Trends Table 10. Pet Medical Cannabidiol Industry Drivers Table 11. Pet Medical Cannabidiol Industry Opportunities and Challenges Table 12. Pet Medical Cannabidiol Industry Restraints Table 13. Global Pet Medical Cannabidiol Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Pet Medical Cannabidiol Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Pet Medical Cannabidiol Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Pet Medical Cannabidiol Revenue Market Share by Region (2021-2026) Table 17. Global Pet Medical Cannabidiol Revenue Market Share by Region (2027-2032) Table 18. Global Pet Medical Cannabidiol Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 19. Global Pet Medical Cannabidiol Sales by Region (2021-2026) & (k units) Table 20. Global Pet Medical Cannabidiol Sales by Region (2027-2032) & (k units) Table 21. Global Pet Medical Cannabidiol Sales Market Share by Region (2021-2026) Table 22. Global Pet Medical Cannabidiol Sales Market Share by Region (2027-2032) Table 23. Global Pet Medical Cannabidiol Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Pet Medical Cannabidiol Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Pet Medical Cannabidiol Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Pet Medical Cannabidiol Sales Market Share by Manufacturers (2021-2026) Table 27. Global Pet Medical Cannabidiol Sales Price (USD/unit) of Manufacturers (2021-2026) Table 28. Global Pet Medical Cannabidiol Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Pet Medical Cannabidiol Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Pet Medical Cannabidiol Manufacturers, Product Type & Application Table 31. Global Pet Medical Cannabidiol Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Pet Medical Cannabidiol by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Pet Medical Cannabidiol Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Pet Medical Cannabidiol Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Pet Medical Cannabidiol Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Pet Medical Cannabidiol Revenue Market Share by Type (2021-2026) Table 38. Global Pet Medical Cannabidiol Revenue Market Share by Type (2027-2032) Table 39. Global Pet Medical Cannabidiol Sales by Type 2021 VS 2025 VS 2032 (k units) Table 40. Global Pet Medical Cannabidiol Sales by Type (2021-2026) & (k units) Table 41. Global Pet Medical Cannabidiol Sales by Type (2027-2032) & (k units) Table 42. Global Pet Medical Cannabidiol Sales Market Share by Type (2021-2026) Table 43. Global Pet Medical Cannabidiol Sales Market Share by Type (2027-2032) Table 44. Global Pet Medical Cannabidiol Price by Type (2021-2026) & (USD/unit) Table 45. Global Pet Medical Cannabidiol Price by Type (2027-2032) & (USD/unit) Table 46. Global Pet Medical Cannabidiol Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Pet Medical Cannabidiol Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Pet Medical Cannabidiol Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Pet Medical Cannabidiol Revenue Market Share by Application (2021-2026) Table 50. Global Pet Medical Cannabidiol Revenue Market Share by Application (2027-2032) Table 51. Global Pet Medical Cannabidiol Sales by Application 2021 VS 2025 VS 2032 (k units) Table 52. Global Pet Medical Cannabidiol Sales by Application (2021-2026) & (k units) Table 53. Global Pet Medical Cannabidiol Sales by Application (2027-2032) & (k units) Table 54. Global Pet Medical Cannabidiol Sales Market Share by Application (2021-2026) Table 55. Global Pet Medical Cannabidiol Sales Market Share by Application (2027-2032) Table 56. Global Pet Medical Cannabidiol Price by Application (2021-2026) & (USD/unit) Table 57. Global Pet Medical Cannabidiol Price by Application (2027-2032) & (USD/unit) Table 58. Canna-Pet Company Information Table 59. Canna-Pet Business Overview Table 60. Canna-Pet Pet Medical Cannabidiol Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 61. Canna-Pet Pet Medical Cannabidiol Product Portfolio Table 62. Canna-Pet Recent Development Table 63. Holistic Hound Company Information Table 64. Holistic Hound Business Overview Table 65. Holistic Hound Pet Medical Cannabidiol Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 66. Holistic Hound Pet Medical Cannabidiol Product Portfolio Table 67. Holistic Hound Recent Development Table 68. BATCH Company Information Table 69. BATCH Business Overview Table 70. BATCH Pet Medical Cannabidiol Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 71. BATCH Pet Medical Cannabidiol Product Portfolio Table 72. BATCH Recent Development Table 73. Choom Holdings Company Information Table 74. Choom Holdings Business Overview Table 75. Choom Holdings Pet Medical Cannabidiol Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 76. Choom Holdings Pet Medical Cannabidiol Product Portfolio Table 77. Choom Holdings Recent Development Table 78. Receptra Naturals Company Information Table 79. Receptra Naturals Business Overview Table 80. Receptra Naturals Pet Medical Cannabidiol Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 81. Receptra Naturals Pet Medical Cannabidiol Product Portfolio Table 82. Receptra Naturals Recent Development Table 83. Curaleaf Company Information Table 84. Curaleaf Business Overview Table 85. Curaleaf Pet Medical Cannabidiol Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 86. Curaleaf Pet Medical Cannabidiol Product Portfolio Table 87. Curaleaf Recent Development Table 88. Trulieve Cannabis Company Information Table 89. Trulieve Cannabis Business Overview Table 90. Trulieve Cannabis Pet Medical Cannabidiol Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Trulieve Cannabis Pet Medical Cannabidiol Product Portfolio Table 92. Trulieve Cannabis Recent Development Table 93. Pure Spectrum Company Information Table 94. Pure Spectrum Business Overview Table 95. Pure Spectrum Pet Medical Cannabidiol Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Pure Spectrum Pet Medical Cannabidiol Product Portfolio Table 97. Pure Spectrum Recent Development Table 98. Cannabis Strategies Acquisition Company Information Table 99. Cannabis Strategies Acquisition Business Overview Table 100. Cannabis Strategies Acquisition Pet Medical Cannabidiol Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Cannabis Strategies Acquisition Pet Medical Cannabidiol Product Portfolio Table 102. Cannabis Strategies Acquisition Recent Development Table 103. Pet Releaf Company Information Table 104. Pet Releaf Business Overview Table 105. Pet Releaf Pet Medical Cannabidiol Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Pet Releaf Pet Medical Cannabidiol Product Portfolio Table 107. Pet Releaf Recent Development Table 108. Diamond CBD Company Information Table 109. Diamond CBD Business Overview Table 110. Diamond CBD Pet Medical Cannabidiol Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Diamond CBD Pet Medical Cannabidiol Product Portfolio Table 112. Diamond CBD Recent Development Table 113. PotNetwork Holdings Company Information Table 114. PotNetwork Holdings Business Overview Table 115. PotNetwork Holdings Pet Medical Cannabidiol Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. PotNetwork Holdings Pet Medical Cannabidiol Product Portfolio Table 117. PotNetwork Holdings Recent Development Table 118. Kat's Naturals Company Information Table 119. Kat's Naturals Business Overview Table 120. Kat's Naturals Pet Medical Cannabidiol Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. Kat's Naturals Pet Medical Cannabidiol Product Portfolio Table 122. Kat's Naturals Recent Development Table 123. Bluebird Botanicals Company Information Table 124. Bluebird Botanicals Business Overview Table 125. Bluebird Botanicals Pet Medical Cannabidiol Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 126. Bluebird Botanicals Pet Medical Cannabidiol Product Portfolio Table 127. Bluebird Botanicals Recent Development Table 128. North America Pet Medical Cannabidiol Revenue by Type (2021-2026) & (US$ Million) Table 129. North America Pet Medical Cannabidiol Revenue by Type (2027-2032) & (US$ Million) Table 130. North America Pet Medical Cannabidiol Sales by Type (2021-2026) & (k units) Table 131. North America Pet Medical Cannabidiol Sales by Type (2027-2032) & (k units) Table 132. North America Pet Medical Cannabidiol Sales Price by Type (2021-2026) & (USD/unit) Table 133. North America Pet Medical Cannabidiol Sales Price by Type (2027-2032) & (USD/unit) Table 134. North America Pet Medical Cannabidiol Revenue by Application (2021-2026) & (US$ Million) Table 135. North America Pet Medical Cannabidiol Revenue by Application (2027-2032) & (US$ Million) Table 136. North America Pet Medical Cannabidiol Sales by Application (2021-2026) & (k units) Table 137. North America Pet Medical Cannabidiol Sales by Application (2027-2032) & (k units) Table 138. North America Pet Medical Cannabidiol Sales Price by Application (2021-2026) & (USD/unit) Table 139. North America Pet Medical Cannabidiol Sales Price by Application (2027-2032) & (USD/unit) Table 140. North America Pet Medical Cannabidiol Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 141. North America Pet Medical Cannabidiol Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 142. North America Pet Medical Cannabidiol Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 143. North America Pet Medical Cannabidiol Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 144. North America Pet Medical Cannabidiol Sales by Country (2021-2026) & (k units) Table 145. North America Pet Medical Cannabidiol Sales by Country (2027-2032) & (k units) Table 146. North America Pet Medical Cannabidiol Sales Price by Country (2021-2026) & (USD/unit) Table 147. North America Pet Medical Cannabidiol Sales Price by Country (2027-2032) & (USD/unit) Table 148. United States Pet Medical Cannabidiol Revenue (2021-2032) & (US$ Million) Table 149. Canada Pet Medical Cannabidiol Revenue (2021-2032) & (US$ Million) Table 150. Mexico Pet Medical Cannabidiol Revenue (2021-2032) & (US$ Million) Table 151. Europe Pet Medical Cannabidiol Revenue by Type (2021-2026) & (US$ Million) Table 152. Europe Pet Medical Cannabidiol Revenue by Type (2027-2032) & (US$ Million) Table 153. Europe Pet Medical Cannabidiol Sales by Type (2021-2026) & (k units) Table 154. Europe Pet Medical Cannabidiol Sales by Type (2027-2032) & (k units) Table 155. Europe Pet Medical Cannabidiol Sales Price by Type (2021-2026) & (USD/unit) Table 156. Europe Pet Medical Cannabidiol Sales Price by Type (2027-2032) & (USD/unit) Table 157. Europe Pet Medical Cannabidiol Revenue by Application (2021-2026) & (US$ Million) Table 158. Europe Pet Medical Cannabidiol Revenue by Application (2027-2032) & (US$ Million) Table 159. Europe Pet Medical Cannabidiol Sales by Application (2021-2026) & (k units) Table 160. Europe Pet Medical Cannabidiol Sales by Application (2027-2032) & (k units) Table 161. Europe Pet Medical Cannabidiol Sales Price by Application (2021-2026) & (USD/unit) Table 162. Europe Pet Medical Cannabidiol Sales Price by Application (2027-2032) & (USD/unit) Table 163. Europe Pet Medical Cannabidiol Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 164. Europe Pet Medical Cannabidiol Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 165. Europe Pet Medical Cannabidiol Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 166. Europe Pet Medical Cannabidiol Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 167. Europe Pet Medical Cannabidiol Sales by Country (2021-2026) & (k units) Table 168. Europe Pet Medical Cannabidiol Sales by Country (2027-2032) & (k units) Table 169. Europe Pet Medical Cannabidiol Sales Price by Country (2021-2026) & (USD/unit) Table 170. Europe Pet Medical Cannabidiol Sales Price by Country (2027-2032) & (USD/unit) Table 171. Germany Pet Medical Cannabidiol Revenue (2021-2032) & (US$ Million) Table 172. France Pet Medical Cannabidiol Revenue (2021-2032) & (US$ Million) Table 173. U.K. Pet Medical Cannabidiol Revenue (2021-2032) & (US$ Million) Table 174. Italy Pet Medical Cannabidiol Revenue (2021-2032) & (US$ Million) Table 175. Russia Pet Medical Cannabidiol Revenue (2021-2032) & (US$ Million) Table 176. Spain Pet Medical Cannabidiol Revenue (2021-2032) & (US$ Million) Table 177. Netherlands Pet Medical Cannabidiol Revenue (2021-2032) & (US$ Million) Table 178. Switzerland Pet Medical Cannabidiol Revenue (2021-2032) & (US$ Million) Table 179. Sweden Pet Medical Cannabidiol Revenue (2021-2032) & (US$ Million) Table 180. Poland Pet Medical Cannabidiol Revenue (2021-2032) & (US$ Million) Table 181. China Pet Medical Cannabidiol Revenue by Type (2021-2026) & (US$ Million) Table 182. China Pet Medical Cannabidiol Revenue by Type (2027-2032) & (US$ Million) Table 183. China Pet Medical Cannabidiol Sales by Type (2021-2026) & (k units) Table 184. China Pet Medical Cannabidiol Sales by Type (2027-2032) & (k units) Table 185. China Pet Medical Cannabidiol Sales Price by Type (2021-2026) & (USD/unit) Table 186. China Pet Medical Cannabidiol Sales Price by Type (2027-2032) & (USD/unit) Table 187. China Pet Medical Cannabidiol Revenue by Application (2021-2026) & (US$ Million) Table 188. China Pet Medical Cannabidiol Revenue by Application (2027-2032) & (US$ Million) Table 189. China Pet Medical Cannabidiol Sales by Application (2021-2026) & (k units) Table 190. China Pet Medical Cannabidiol Sales by Application (2027-2032) & (k units) Table 191. China Pet Medical Cannabidiol Sales Price by Application (2021-2026) & (USD/unit) Table 192. China Pet Medical Cannabidiol Sales Price by Application (2027-2032) & (USD/unit) Table 193. Asia Pet Medical Cannabidiol Revenue by Type (2021-2026) & (US$ Million) Table 194. Asia Pet Medical Cannabidiol Revenue by Type (2027-2032) & (US$ Million) Table 195. Asia Pet Medical Cannabidiol Sales by Type (2021-2026) & (k units) Table 196. Asia Pet Medical Cannabidiol Sales by Type (2027-2032) & (k units) Table 197. Asia Pet Medical Cannabidiol Sales Price by Type (2021-2026) & (USD/unit) Table 198. Asia Pet Medical Cannabidiol Sales Price by Type (2027-2032) & (USD/unit) Table 199. Asia Pet Medical Cannabidiol Revenue by Application (2021-2026) & (US$ Million) Table 200. Asia Pet Medical Cannabidiol Revenue by Application (2027-2032) & (US$ Million) Table 201. Asia Pet Medical Cannabidiol Sales by Application (2021-2026) & (k units) Table 202. Asia Pet Medical Cannabidiol Sales by Application (2027-2032) & (k units) Table 203. Asia Pet Medical Cannabidiol Sales Price by Application (2021-2026) & (USD/unit) Table 204. Asia Pet Medical Cannabidiol Sales Price by Application (2027-2032) & (USD/unit) Table 205. Asia Pet Medical Cannabidiol Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 206. Asia Pet Medical Cannabidiol Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 207. Asia Pet Medical Cannabidiol Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 208. Asia Pet Medical Cannabidiol Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 209. Asia Pet Medical Cannabidiol Sales by Country (2021-2026) & (k units) Table 210. Asia Pet Medical Cannabidiol Sales by Country (2027-2032) & (k units) Table 211. Asia Pet Medical Cannabidiol Sales Price by Country (2021-2026) & (USD/unit) Table 212. Asia Pet Medical Cannabidiol Sales Price by Country (2027-2032) & (USD/unit) Table 213. Japan Pet Medical Cannabidiol Revenue (2021-2032) & (US$ Million) Table 214. South Korea Pet Medical Cannabidiol Revenue (2021-2032) & (US$ Million) Table 215. India Pet Medical Cannabidiol Revenue (2021-2032) & (US$ Million) Table 216. Australia Pet Medical Cannabidiol Revenue (2021-2032) & (US$ Million) Table 217. Taiwan Pet Medical Cannabidiol Revenue (2021-2032) & (US$ Million) Table 218. Southeast Asia Pet Medical Cannabidiol Revenue (2021-2032) & (US$ Million) Table 219. SAMEA Pet Medical Cannabidiol Revenue by Type (2021-2026) & (US$ Million) Table 220. SAMEA Pet Medical Cannabidiol Revenue by Type (2027-2032) & (US$ Million) Table 221. SAMEA Pet Medical Cannabidiol Sales by Type (2021-2026) & (k units) Table 222. SAMEA Pet Medical Cannabidiol Sales by Type (2027-2032) & (k units) Table 223. SAMEA Pet Medical Cannabidiol Sales Price by Type (2021-2026) & (USD/unit) Table 224. SAMEA Pet Medical Cannabidiol Sales Price by Type (2027-2032) & (USD/unit) Table 225. SAMEA Pet Medical Cannabidiol Revenue by Application (2021-2026) & (US$ Million) Table 226. SAMEA Pet Medical Cannabidiol Revenue by Application (2027-2032) & (US$ Million) Table 227. SAMEA Pet Medical Cannabidiol Sales by Application (2021-2026) & (k units) Table 228. SAMEA Pet Medical Cannabidiol Sales by Application (2027-2032) & (k units) Table 229. SAMEA Pet Medical Cannabidiol Sales Price by Application (2021-2026) & (USD/unit) Table 230. SAMEA Pet Medical Cannabidiol Sales Price by Application (2027-2032) & (USD/unit) Table 231. SAMEA Pet Medical Cannabidiol Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 232. SAMEA Pet Medical Cannabidiol Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 233. SAMEA Pet Medical Cannabidiol Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 234. SAMEA Pet Medical Cannabidiol Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 235. SAMEA Pet Medical Cannabidiol Sales by Country (2021-2026) & (k units) Table 236. SAMEA Pet Medical Cannabidiol Sales by Country (2027-2032) & (k units) Table 237. SAMEA Pet Medical Cannabidiol Sales Price by Country (2021-2026) & (USD/unit) Table 238. SAMEA Pet Medical Cannabidiol Sales Price by Country (2027-2032) & (USD/unit) Table 239. Brazil Pet Medical Cannabidiol Revenue (2021-2032) & (US$ Million) Table 240. Argentina Pet Medical Cannabidiol Revenue (2021-2032) & (US$ Million) Table 241. Chile Pet Medical Cannabidiol Revenue (2021-2032) & (US$ Million) Table 242. Colombia Pet Medical Cannabidiol Revenue (2021-2032) & (US$ Million) Table 243. Peru Pet Medical Cannabidiol Revenue (2021-2032) & (US$ Million) Table 244. Saudi Arabia Pet Medical Cannabidiol Revenue (2021-2032) & (US$ Million) Table 245. Israel Pet Medical Cannabidiol Revenue (2021-2032) & (US$ Million) Table 246. UAE Pet Medical Cannabidiol Revenue (2021-2032) & (US$ Million) Table 247. Turkey Pet Medical Cannabidiol Revenue (2021-2032) & (US$ Million) Table 248. Iran Pet Medical Cannabidiol Revenue (2021-2032) & (US$ Million) Table 249. Egypt Pet Medical Cannabidiol Revenue (2021-2032) & (US$ Million) Table 250. Key Raw Materials Table 251. Raw Materials Key Suppliers Table 252. Pet Medical Cannabidiol Distributors List Table 253. Pet Medical Cannabidiol Customers List Table 254. Research Programs/Design for This Report Table 255. Authors List of This Report Table 256. Secondary Sources Table 257. Primary Sources List of Figures Figure 1. Pet Medical Cannabidiol Image Figure 2. Global Pet Medical Cannabidiol Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pet Medical Cannabidiol Market Size Share 2021 VS 2025 VS 2032 Figure 4. Oral Cannabidiol Image Figure 5. Topical Cannabidiol Image Figure 6. Global Pet Medical Cannabidiol Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Pet Medical Cannabidiol Market Size Share 2021 VS 2025 VS 2032 Figure 8. Anaesthetization Image Figure 9. Stimulate Appetite Image Figure 10. Relieve Anxiety Image Figure 11. Others Image Figure 12. Global Pet Medical Cannabidiol Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Pet Medical Cannabidiol Revenue (2021-2032) & (US$ Million) Figure 14. Global Pet Medical Cannabidiol Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Pet Medical Cannabidiol Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Pet Medical Cannabidiol Revenue Market Share by Region (2021-2032) Figure 17. Global Pet Medical Cannabidiol Sales (2021-2032) & (k units) Figure 18. Global Pet Medical Cannabidiol Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 19. Global Pet Medical Cannabidiol Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Pet Medical Cannabidiol Sales YoY (2021-2032) & (k units) Figure 21. Europe Pet Medical Cannabidiol Sales YoY (2021-2032) & (k units) Figure 22. China Pet Medical Cannabidiol Sales YoY (2021-2032) & (k units) Figure 23. Asia (Excluding China) Pet Medical Cannabidiol Sales YoY (2021-2032) & (k units) Figure 24. South America, Middle East and Africa Pet Medical Cannabidiol Sales YoY (2021-2032) & (k units) Figure 25. Global Pet Medical Cannabidiol Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Pet Medical Cannabidiol Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Pet Medical Cannabidiol Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Pet Medical Cannabidiol Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Pet Medical Cannabidiol Revenue Market Share by Type (2021-2032) Figure 31. Global Pet Medical Cannabidiol Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 32. Global Pet Medical Cannabidiol Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Pet Medical Cannabidiol Sales Market Share by Type (2021-2032) Figure 34. Global Pet Medical Cannabidiol Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Pet Medical Cannabidiol Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Pet Medical Cannabidiol Revenue Market Share by Application (2021-2032) Figure 37. Global Pet Medical Cannabidiol Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 38. Global Pet Medical Cannabidiol Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Pet Medical Cannabidiol Sales Market Share by Application (2021-2032) Figure 40. North America Pet Medical Cannabidiol Revenue Share by Type (2021-2032) Figure 41. North America Pet Medical Cannabidiol Sales Share by Type (2021-2032) Figure 42. North America Pet Medical Cannabidiol Revenue Share by Application (2021-2032) Figure 43. North America Pet Medical Cannabidiol Sales Share by Application (2021-2032) Figure 44. North America Pet Medical Cannabidiol Revenue Share by Country (2021-2032) Figure 45. North America Pet Medical Cannabidiol Sales Share by Country (2021-2032) Figure 46. Europe Pet Medical Cannabidiol Revenue Share by Type (2021-2032) Figure 47. Europe Pet Medical Cannabidiol Sales Share by Type (2021-2032) Figure 48. Europe Pet Medical Cannabidiol Revenue Share by Application (2021-2032) Figure 49. Europe Pet Medical Cannabidiol Sales Share by Application (2021-2032) Figure 50. Europe Pet Medical Cannabidiol Revenue Share by Country (2021-2032) Figure 51. Europe Pet Medical Cannabidiol Sales Share by Country (2021-2032) Figure 52. China Pet Medical Cannabidiol Revenue Share by Type (2021-2032) Figure 53. China Pet Medical Cannabidiol Sales Share by Type (2021-2032) Figure 54. China Pet Medical Cannabidiol Revenue Share by Application (2021-2032) Figure 55. China Pet Medical Cannabidiol Sales Share by Application (2021-2032) Figure 56. Asia Pet Medical Cannabidiol Revenue Share by Type (2021-2032) Figure 57. Asia Pet Medical Cannabidiol Sales Share by Type (2021-2032) Figure 58. Asia Pet Medical Cannabidiol Revenue Share by Application (2021-2032) Figure 59. Asia Pet Medical Cannabidiol Sales Share by Application (2021-2032) Figure 60. Asia Pet Medical Cannabidiol Revenue Share by Country (2021-2032) Figure 61. Asia Pet Medical Cannabidiol Sales Share by Country (2021-2032) Figure 62. SAMEA Pet Medical Cannabidiol Revenue Share by Type (2021-2032) Figure 63. SAMEA Pet Medical Cannabidiol Sales Share by Type (2021-2032) Figure 64. SAMEA Pet Medical Cannabidiol Revenue Share by Application (2021-2032) Figure 65. SAMEA Pet Medical Cannabidiol Sales Share by Application (2021-2032) Figure 66. SAMEA Pet Medical Cannabidiol Revenue Share by Country (2021-2032) Figure 67. SAMEA Pet Medical Cannabidiol Sales Share by Country (2021-2032) Figure 68. Pet Medical Cannabidiol Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Pet Medical Cannabidiol Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Oral Cannabidiol
  • Topical Cannabidiol
Applications
  • Anaesthetization
  • Stimulate Appetite
  • Relieve Anxiety
  • Others
Companies covered
  • Canna-Pet
  • Holistic Hound
  • BATCH
  • Choom Holdings
  • Receptra Naturals
  • Curaleaf
  • Trulieve Cannabis
  • Pure Spectrum
  • Cannabis Strategies Acquisition
  • Pet Releaf
  • Diamond CBD
  • PotNetwork Holdings
  • Kat's Naturals
  • Bluebird Botanicals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Pet Medical Cannabidiol Market by Type
  3. 1.2.1 Global Pet Medical Cannabidiol Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Oral Cannabidiol
  5. 1.2.3 Topical Cannabidiol
  6. 1.3 Pet Medical Cannabidiol Market by Application
  7. 1.3.1 Global Pet Medical Cannabidiol Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Anaesthetization
  9. 1.3.3 Stimulate Appetite
  10. 1.3.4 Relieve Anxiety
  11. 1.3.5 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Pet Medical Cannabidiol Market Dynamics
  1. 2.1 Pet Medical Cannabidiol Industry Trends
  2. 2.2 Pet Medical Cannabidiol Industry Drivers
  3. 2.3 Pet Medical Cannabidiol Industry Opportunities and Challenges
  4. 2.4 Pet Medical Cannabidiol Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Pet Medical Cannabidiol Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Pet Medical Cannabidiol Revenue by Region
  3. 3.2.1 Global Pet Medical Cannabidiol Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Pet Medical Cannabidiol Revenue by Region (2021-2026)
  5. 3.2.3 Global Pet Medical Cannabidiol Revenue by Region (2027-2032)
  6. 3.2.4 Global Pet Medical Cannabidiol Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Pet Medical Cannabidiol Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Pet Medical Cannabidiol Sales by Region
  9. 3.4.1 Global Pet Medical Cannabidiol Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Pet Medical Cannabidiol Sales by Region (2021-2026)
  11. 3.4.3 Global Pet Medical Cannabidiol Sales by Region (2027-2032)
  12. 3.4.4 Global Pet Medical Cannabidiol Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Pet Medical Cannabidiol Revenue by Manufacturers
  2. 4.1.1 Global Pet Medical Cannabidiol Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Pet Medical Cannabidiol Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Pet Medical Cannabidiol Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Pet Medical Cannabidiol Sales by Manufacturers
  6. 4.2.1 Global Pet Medical Cannabidiol Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Pet Medical Cannabidiol Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Pet Medical Cannabidiol Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Pet Medical Cannabidiol Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Pet Medical Cannabidiol Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Pet Medical Cannabidiol Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Pet Medical Cannabidiol Manufacturers, Product Type & Application
  13. 4.7 Global Pet Medical Cannabidiol Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Pet Medical Cannabidiol Market CR5 and HHI
  16. 4.8.2 2025 Pet Medical Cannabidiol Tier 1, Tier 2, and Tier 3
5 Pet Medical Cannabidiol Market by Type
  1. 5.1 Global Pet Medical Cannabidiol Revenue by Type
  2. 5.1.1 Global Pet Medical Cannabidiol Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Pet Medical Cannabidiol Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Pet Medical Cannabidiol Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Pet Medical Cannabidiol Sales by Type
  6. 5.2.1 Global Pet Medical Cannabidiol Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pet Medical Cannabidiol Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Pet Medical Cannabidiol Sales Market Share by Type (2021-2032)
  9. 5.3 Global Pet Medical Cannabidiol Price by Type
6 Pet Medical Cannabidiol Market by Application
  1. 6.1 Global Pet Medical Cannabidiol Revenue by Application
  2. 6.1.1 Global Pet Medical Cannabidiol Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Pet Medical Cannabidiol Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Pet Medical Cannabidiol Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Pet Medical Cannabidiol Sales by Application
  6. 6.2.1 Global Pet Medical Cannabidiol Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Pet Medical Cannabidiol Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Pet Medical Cannabidiol Sales Market Share by Application (2021-2032)
  9. 6.3 Global Pet Medical Cannabidiol Price by Application
7 Company Profiles
  1. 7.1 Canna-Pet
  2. 7.1.1 Canna-Pet Company Information
  3. 7.1.2 Canna-Pet Business Overview
  4. 7.1.3 Canna-Pet Pet Medical Cannabidiol Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Canna-Pet Pet Medical Cannabidiol Product Portfolio
  6. 7.1.5 Canna-Pet Recent Developments
  7. 7.2 Holistic Hound
  8. 7.2.1 Holistic Hound Company Information
  9. 7.2.2 Holistic Hound Business Overview
  10. 7.2.3 Holistic Hound Pet Medical Cannabidiol Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Holistic Hound Pet Medical Cannabidiol Product Portfolio
  12. 7.2.5 Holistic Hound Recent Developments
  13. 7.3 BATCH
  14. 7.3.1 BATCH Company Information
  15. 7.3.2 BATCH Business Overview
  16. 7.3.3 BATCH Pet Medical Cannabidiol Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 BATCH Pet Medical Cannabidiol Product Portfolio
  18. 7.3.5 BATCH Recent Developments
  19. 7.4 Choom Holdings
  20. 7.4.1 Choom Holdings Company Information
  21. 7.4.2 Choom Holdings Business Overview
  22. 7.4.3 Choom Holdings Pet Medical Cannabidiol Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Choom Holdings Pet Medical Cannabidiol Product Portfolio
  24. 7.4.5 Choom Holdings Recent Developments
  25. 7.5 Receptra Naturals
  26. 7.5.1 Receptra Naturals Company Information
  27. 7.5.2 Receptra Naturals Business Overview
  28. 7.5.3 Receptra Naturals Pet Medical Cannabidiol Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Receptra Naturals Pet Medical Cannabidiol Product Portfolio
  30. 7.5.5 Receptra Naturals Recent Developments
  31. 7.6 Curaleaf
  32. 7.6.1 Curaleaf Company Information
  33. 7.6.2 Curaleaf Business Overview
  34. 7.6.3 Curaleaf Pet Medical Cannabidiol Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Curaleaf Pet Medical Cannabidiol Product Portfolio
  36. 7.6.5 Curaleaf Recent Developments
  37. 7.7 Trulieve Cannabis
  38. 7.7.1 Trulieve Cannabis Company Information
  39. 7.7.2 Trulieve Cannabis Business Overview
  40. 7.7.3 Trulieve Cannabis Pet Medical Cannabidiol Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Trulieve Cannabis Pet Medical Cannabidiol Product Portfolio
  42. 7.7.5 Trulieve Cannabis Recent Developments
  43. 7.8 Pure Spectrum
  44. 7.8.1 Pure Spectrum Company Information
  45. 7.8.2 Pure Spectrum Business Overview
  46. 7.8.3 Pure Spectrum Pet Medical Cannabidiol Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Pure Spectrum Pet Medical Cannabidiol Product Portfolio
  48. 7.8.5 Pure Spectrum Recent Developments
  49. 7.9 Cannabis Strategies Acquisition
  50. 7.9.1 Cannabis Strategies Acquisition Company Information
  51. 7.9.2 Cannabis Strategies Acquisition Business Overview
  52. 7.9.3 Cannabis Strategies Acquisition Pet Medical Cannabidiol Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Cannabis Strategies Acquisition Pet Medical Cannabidiol Product Portfolio
  54. 7.9.5 Cannabis Strategies Acquisition Recent Developments
  55. 7.10 Pet Releaf
  56. 7.10.1 Pet Releaf Company Information
  57. 7.10.2 Pet Releaf Business Overview
  58. 7.10.3 Pet Releaf Pet Medical Cannabidiol Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Pet Releaf Pet Medical Cannabidiol Product Portfolio
  60. 7.10.5 Pet Releaf Recent Developments
  61. 7.11 Diamond CBD
  62. 7.11.1 Diamond CBD Company Information
  63. 7.11.2 Diamond CBD Business Overview
  64. 7.11.3 Diamond CBD Pet Medical Cannabidiol Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Diamond CBD Pet Medical Cannabidiol Product Portfolio
  66. 7.11.5 Diamond CBD Recent Developments
  67. 7.12 PotNetwork Holdings
  68. 7.12.1 PotNetwork Holdings Company Information
  69. 7.12.2 PotNetwork Holdings Business Overview
  70. 7.12.3 PotNetwork Holdings Pet Medical Cannabidiol Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 PotNetwork Holdings Pet Medical Cannabidiol Product Portfolio
  72. 7.12.5 PotNetwork Holdings Recent Developments
  73. 7.13 Kat's Naturals
  74. 7.13.1 Kat's Naturals Company Information
  75. 7.13.2 Kat's Naturals Business Overview
  76. 7.13.3 Kat's Naturals Pet Medical Cannabidiol Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Kat's Naturals Pet Medical Cannabidiol Product Portfolio
  78. 7.13.5 Kat's Naturals Recent Developments
  79. 7.14 Bluebird Botanicals
  80. 7.14.1 Bluebird Botanicals Company Information
  81. 7.14.2 Bluebird Botanicals Business Overview
  82. 7.14.3 Bluebird Botanicals Pet Medical Cannabidiol Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Bluebird Botanicals Pet Medical Cannabidiol Product Portfolio
  84. 7.14.5 Bluebird Botanicals Recent Developments
8 North America
  1. 8.1 North America Pet Medical Cannabidiol Market Size by Type
  2. 8.1.1 North America Pet Medical Cannabidiol Revenue by Type (2021-2032)
  3. 8.1.2 North America Pet Medical Cannabidiol Sales by Type (2021-2032)
  4. 8.1.3 North America Pet Medical Cannabidiol Price by Type (2021-2032)
  5. 8.2 North America Pet Medical Cannabidiol Market Size by Application
  6. 8.2.1 North America Pet Medical Cannabidiol Revenue by Application (2021-2032)
  7. 8.2.2 North America Pet Medical Cannabidiol Sales by Application (2021-2032)
  8. 8.2.3 North America Pet Medical Cannabidiol Price by Application (2021-2032)
  9. 8.3 North America Pet Medical Cannabidiol Market Size by Country
  10. 8.3.1 North America Pet Medical Cannabidiol Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Pet Medical Cannabidiol Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Pet Medical Cannabidiol Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Pet Medical Cannabidiol Market Size by Type
  2. 9.1.1 Europe Pet Medical Cannabidiol Revenue by Type (2021-2032)
  3. 9.1.2 Europe Pet Medical Cannabidiol Sales by Type (2021-2032)
  4. 9.1.3 Europe Pet Medical Cannabidiol Price by Type (2021-2032)
  5. 9.2 Europe Pet Medical Cannabidiol Market Size by Application
  6. 9.2.1 Europe Pet Medical Cannabidiol Revenue by Application (2021-2032)
  7. 9.2.2 Europe Pet Medical Cannabidiol Sales by Application (2021-2032)
  8. 9.2.3 Europe Pet Medical Cannabidiol Price by Application (2021-2032)
  9. 9.3 Europe Pet Medical Cannabidiol Market Size by Country
  10. 9.3.1 Europe Pet Medical Cannabidiol Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Pet Medical Cannabidiol Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Pet Medical Cannabidiol Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Pet Medical Cannabidiol Market Size by Type
  2. 10.1.1 China Pet Medical Cannabidiol Revenue by Type (2021-2032)
  3. 10.1.2 China Pet Medical Cannabidiol Sales by Type (2021-2032)
  4. 10.1.3 China Pet Medical Cannabidiol Price by Type (2021-2032)
  5. 10.2 China Pet Medical Cannabidiol Market Size by Application
  6. 10.2.1 China Pet Medical Cannabidiol Revenue by Application (2021-2032)
  7. 10.2.2 China Pet Medical Cannabidiol Sales by Application (2021-2032)
  8. 10.2.3 China Pet Medical Cannabidiol Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Pet Medical Cannabidiol Market Size by Type
  2. 11.1.1 Asia Pet Medical Cannabidiol Revenue by Type (2021-2032)
  3. 11.1.2 Asia Pet Medical Cannabidiol Sales by Type (2021-2032)
  4. 11.1.3 Asia Pet Medical Cannabidiol Price by Type (2021-2032)
  5. 11.2 Asia Pet Medical Cannabidiol Market Size by Application
  6. 11.2.1 Asia Pet Medical Cannabidiol Revenue by Application (2021-2032)
  7. 11.2.2 Asia Pet Medical Cannabidiol Sales by Application (2021-2032)
  8. 11.2.3 Asia Pet Medical Cannabidiol Price by Application (2021-2032)
  9. 11.3 Asia Pet Medical Cannabidiol Market Size by Country
  10. 11.3.1 Asia Pet Medical Cannabidiol Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Pet Medical Cannabidiol Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Pet Medical Cannabidiol Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Pet Medical Cannabidiol Market Size by Type
  2. 12.1.1 SAMEA Pet Medical Cannabidiol Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Pet Medical Cannabidiol Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Pet Medical Cannabidiol Price by Type (2021-2032)
  5. 12.2 SAMEA Pet Medical Cannabidiol Market Size by Application
  6. 12.2.1 SAMEA Pet Medical Cannabidiol Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Pet Medical Cannabidiol Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Pet Medical Cannabidiol Price by Application (2021-2032)
  9. 12.3 SAMEA Pet Medical Cannabidiol Market Size by Country
  10. 12.3.1 SAMEA Pet Medical Cannabidiol Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Pet Medical Cannabidiol Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Pet Medical Cannabidiol Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Pet Medical Cannabidiol Value Chain Analysis
  2. 13.1.1 Pet Medical Cannabidiol Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Pet Medical Cannabidiol Production Mode & Process
  6. 13.2 Pet Medical Cannabidiol Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Pet Medical Cannabidiol Distributors
  9. 13.2.3 Pet Medical Cannabidiol Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst